Skin Disease Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 63 pages | ID: SB3A89979790EN
Market Monitor Global

Abstracts

Skin Disease is a general term for diseases that occur in the skin and skin accessory organs. There are many types of it, and visceral diseases can also be manifested on the skin.

This report contains market size and forecasts of Skin Disease Treatment in Global, including the following market information:

Global Skin Disease Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Skin Disease Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Medicated Creams and Ointments Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Skin Disease Treatment include APEIRON Biologics AG, HanAll BioPharma, GlaxoSmithKline plc., Allergen, Plc., Anacor Pharmaceuticals, Celgene, Basilea Pharmaceutica, Cipher Pharmaceuticals and Agenus, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Skin Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Skin Disease Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Skin Disease Treatment Market Segment Percentages, by Type, 2021 (%)

• Medicated Creams and Ointments
• Antibiotics
• Vitamins and Steroids
• Antihistamines
• Laser Therapy
• Antifungals
• Others

Global Skin Disease Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Skin Disease Treatment Market Segment Percentages, by Application, 2021 (%)

• Dermatology Clinics
• Skincare Clinics
• Hospitals
• Aesthetic Centers
• Others

Global Skin Disease Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Skin Disease Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Skin Disease Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Skin Disease Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• APEIRON Biologics AG
• HanAll BioPharma
• GlaxoSmithKline plc.
• Allergen, Plc.
• Anacor Pharmaceuticals
• Celgene
• Basilea Pharmaceutica
• Cipher Pharmaceuticals
• Agenus
• Astion Pharma A/S
• Bristol-Myers Squibb
• Almirall S.A.
• Galderma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Skin Disease Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Skin Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL SKIN DISEASE TREATMENT OVERALL MARKET SIZE

2.1 Global Skin Disease Treatment Market Size: 2021 VS 2028
2.2 Global Skin Disease Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Skin Disease Treatment Players in Global Market
3.2 Top Global Skin Disease Treatment Companies Ranked by Revenue
3.3 Global Skin Disease Treatment Revenue by Companies
3.4 Top 3 and Top 5 Skin Disease Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Skin Disease Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Skin Disease Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Skin Disease Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Skin Disease Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Skin Disease Treatment Market Size Markets, 2021 & 2028
  4.1.2 Medicated Creams and Ointments
  4.1.3 Antibiotics
  4.1.4 Vitamins and Steroids
  4.1.5 Antihistamines
  4.1.6 Laser Therapy
  4.1.7 Antifungals
  4.1.8 Others
4.2 By Type - Global Skin Disease Treatment Revenue & Forecasts
  4.2.1 By Type - Global Skin Disease Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Skin Disease Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Skin Disease Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Skin Disease Treatment Market Size, 2021 & 2028
  5.1.2 Dermatology Clinics
  5.1.3 Skincare Clinics
  5.1.4 Hospitals
  5.1.5 Aesthetic Centers
  5.1.6 Others
5.2 By Application - Global Skin Disease Treatment Revenue & Forecasts
  5.2.1 By Application - Global Skin Disease Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Skin Disease Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Skin Disease Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Skin Disease Treatment Market Size, 2021 & 2028
6.2 By Region - Global Skin Disease Treatment Revenue & Forecasts
  6.2.1 By Region - Global Skin Disease Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Skin Disease Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Skin Disease Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Skin Disease Treatment Revenue, 2017-2028
  6.3.2 US Skin Disease Treatment Market Size, 2017-2028
  6.3.3 Canada Skin Disease Treatment Market Size, 2017-2028
  6.3.4 Mexico Skin Disease Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Skin Disease Treatment Revenue, 2017-2028
  6.4.2 Germany Skin Disease Treatment Market Size, 2017-2028
  6.4.3 France Skin Disease Treatment Market Size, 2017-2028
  6.4.4 U.K. Skin Disease Treatment Market Size, 2017-2028
  6.4.5 Italy Skin Disease Treatment Market Size, 2017-2028
  6.4.6 Russia Skin Disease Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Skin Disease Treatment Market Size, 2017-2028
  6.4.8 Benelux Skin Disease Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Skin Disease Treatment Revenue, 2017-2028
  6.5.2 China Skin Disease Treatment Market Size, 2017-2028
  6.5.3 Japan Skin Disease Treatment Market Size, 2017-2028
  6.5.4 South Korea Skin Disease Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Skin Disease Treatment Market Size, 2017-2028
  6.5.6 India Skin Disease Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Skin Disease Treatment Revenue, 2017-2028
  6.6.2 Brazil Skin Disease Treatment Market Size, 2017-2028
  6.6.3 Argentina Skin Disease Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Skin Disease Treatment Revenue, 2017-2028
  6.7.2 Turkey Skin Disease Treatment Market Size, 2017-2028
  6.7.3 Israel Skin Disease Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Skin Disease Treatment Market Size, 2017-2028
  6.7.5 UAE Skin Disease Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 APEIRON Biologics AG
  7.1.1 APEIRON Biologics AG Corporate Summary
  7.1.2 APEIRON Biologics AG Business Overview
  7.1.3 APEIRON Biologics AG Skin Disease Treatment Major Product Offerings
  7.1.4 APEIRON Biologics AG Skin Disease Treatment Revenue in Global Market (2017-2022)
  7.1.5 APEIRON Biologics AG Key News
7.2 HanAll BioPharma
  7.2.1 HanAll BioPharma Corporate Summary
  7.2.2 HanAll BioPharma Business Overview
  7.2.3 HanAll BioPharma Skin Disease Treatment Major Product Offerings
  7.2.4 HanAll BioPharma Skin Disease Treatment Revenue in Global Market (2017-2022)
  7.2.5 HanAll BioPharma Key News
7.3 GlaxoSmithKline plc.
  7.3.1 GlaxoSmithKline plc. Corporate Summary
  7.3.2 GlaxoSmithKline plc. Business Overview
  7.3.3 GlaxoSmithKline plc. Skin Disease Treatment Major Product Offerings
  7.3.4 GlaxoSmithKline plc. Skin Disease Treatment Revenue in Global Market (2017-2022)
  7.3.5 GlaxoSmithKline plc. Key News
7.4 Allergen, Plc.
  7.4.1 Allergen, Plc. Corporate Summary
  7.4.2 Allergen, Plc. Business Overview
  7.4.3 Allergen, Plc. Skin Disease Treatment Major Product Offerings
  7.4.4 Allergen, Plc. Skin Disease Treatment Revenue in Global Market (2017-2022)
  7.4.5 Allergen, Plc. Key News
7.5 Anacor Pharmaceuticals
  7.5.1 Anacor Pharmaceuticals Corporate Summary
  7.5.2 Anacor Pharmaceuticals Business Overview
  7.5.3 Anacor Pharmaceuticals Skin Disease Treatment Major Product Offerings
  7.5.4 Anacor Pharmaceuticals Skin Disease Treatment Revenue in Global Market (2017-2022)
  7.5.5 Anacor Pharmaceuticals Key News
7.6 Celgene
  7.6.1 Celgene Corporate Summary
  7.6.2 Celgene Business Overview
  7.6.3 Celgene Skin Disease Treatment Major Product Offerings
  7.6.4 Celgene Skin Disease Treatment Revenue in Global Market (2017-2022)
  7.6.5 Celgene Key News
7.7 Basilea Pharmaceutica
  7.7.1 Basilea Pharmaceutica Corporate Summary
  7.7.2 Basilea Pharmaceutica Business Overview
  7.7.3 Basilea Pharmaceutica Skin Disease Treatment Major Product Offerings
  7.7.4 Basilea Pharmaceutica Skin Disease Treatment Revenue in Global Market (2017-2022)
  7.7.5 Basilea Pharmaceutica Key News
7.8 Cipher Pharmaceuticals
  7.8.1 Cipher Pharmaceuticals Corporate Summary
  7.8.2 Cipher Pharmaceuticals Business Overview
  7.8.3 Cipher Pharmaceuticals Skin Disease Treatment Major Product Offerings
  7.8.4 Cipher Pharmaceuticals Skin Disease Treatment Revenue in Global Market (2017-2022)
  7.8.5 Cipher Pharmaceuticals Key News
7.9 Agenus
  7.9.1 Agenus Corporate Summary
  7.9.2 Agenus Business Overview
  7.9.3 Agenus Skin Disease Treatment Major Product Offerings
  7.9.4 Agenus Skin Disease Treatment Revenue in Global Market (2017-2022)
  7.9.5 Agenus Key News
7.10 Astion Pharma A/S
  7.10.1 Astion Pharma A/S Corporate Summary
  7.10.2 Astion Pharma A/S Business Overview
  7.10.3 Astion Pharma A/S Skin Disease Treatment Major Product Offerings
  7.10.4 Astion Pharma A/S Skin Disease Treatment Revenue in Global Market (2017-2022)
  7.10.5 Astion Pharma A/S Key News
7.11 Bristol-Myers Squibb
  7.11.1 Bristol-Myers Squibb Corporate Summary
  7.11.2 Bristol-Myers Squibb Business Overview
  7.11.3 Bristol-Myers Squibb Skin Disease Treatment Major Product Offerings
  7.11.4 Bristol-Myers Squibb Skin Disease Treatment Revenue in Global Market (2017-2022)
  7.11.5 Bristol-Myers Squibb Key News
7.12 Almirall S.A.
  7.12.1 Almirall S.A. Corporate Summary
  7.12.2 Almirall S.A. Business Overview
  7.12.3 Almirall S.A. Skin Disease Treatment Major Product Offerings
  7.12.4 Almirall S.A. Skin Disease Treatment Revenue in Global Market (2017-2022)
  7.12.5 Almirall S.A. Key News
7.13 Galderma
  7.13.1 Galderma Corporate Summary
  7.13.2 Galderma Business Overview
  7.13.3 Galderma Skin Disease Treatment Major Product Offerings
  7.13.4 Galderma Skin Disease Treatment Revenue in Global Market (2017-2022)
  7.13.5 Galderma Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Skin Disease Treatment Market Opportunities & Trends in Global Market
Table 2. Skin Disease Treatment Market Drivers in Global Market
Table 3. Skin Disease Treatment Market Restraints in Global Market
Table 4. Key Players of Skin Disease Treatment in Global Market
Table 5. Top Skin Disease Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Skin Disease Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Skin Disease Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Skin Disease Treatment Product Type
Table 9. List of Global Tier 1 Skin Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Skin Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Skin Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Skin Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Skin Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Skin Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Skin Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Skin Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Skin Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Skin Disease Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Skin Disease Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Skin Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Skin Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Skin Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Skin Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Skin Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Skin Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Skin Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Skin Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Skin Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Skin Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 30. APEIRON Biologics AG Corporate Summary
Table 31. APEIRON Biologics AG Skin Disease Treatment Product Offerings
Table 32. APEIRON Biologics AG Skin Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 33. HanAll BioPharma Corporate Summary
Table 34. HanAll BioPharma Skin Disease Treatment Product Offerings
Table 35. HanAll BioPharma Skin Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 36. GlaxoSmithKline plc. Corporate Summary
Table 37. GlaxoSmithKline plc. Skin Disease Treatment Product Offerings
Table 38. GlaxoSmithKline plc. Skin Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Allergen, Plc. Corporate Summary
Table 40. Allergen, Plc. Skin Disease Treatment Product Offerings
Table 41. Allergen, Plc. Skin Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Anacor Pharmaceuticals Corporate Summary
Table 43. Anacor Pharmaceuticals Skin Disease Treatment Product Offerings
Table 44. Anacor Pharmaceuticals Skin Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Celgene Corporate Summary
Table 46. Celgene Skin Disease Treatment Product Offerings
Table 47. Celgene Skin Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Basilea Pharmaceutica Corporate Summary
Table 49. Basilea Pharmaceutica Skin Disease Treatment Product Offerings
Table 50. Basilea Pharmaceutica Skin Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Cipher Pharmaceuticals Corporate Summary
Table 52. Cipher Pharmaceuticals Skin Disease Treatment Product Offerings
Table 53. Cipher Pharmaceuticals Skin Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Agenus Corporate Summary
Table 55. Agenus Skin Disease Treatment Product Offerings
Table 56. Agenus Skin Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Astion Pharma A/S Corporate Summary
Table 58. Astion Pharma A/S Skin Disease Treatment Product Offerings
Table 59. Astion Pharma A/S Skin Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Bristol-Myers Squibb Corporate Summary
Table 61. Bristol-Myers Squibb Skin Disease Treatment Product Offerings
Table 62. Bristol-Myers Squibb Skin Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Almirall S.A. Corporate Summary
Table 64. Almirall S.A. Skin Disease Treatment Product Offerings
Table 65. Almirall S.A. Skin Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Galderma Corporate Summary
Table 67. Galderma Skin Disease Treatment Product Offerings
Table 68. Galderma Skin Disease Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Skin Disease Treatment Segment by Type in 2021
Figure 2. Skin Disease Treatment Segment by Application in 2021
Figure 3. Global Skin Disease Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Skin Disease Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Skin Disease Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Skin Disease Treatment Revenue in 2021
Figure 8. By Type - Global Skin Disease Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Skin Disease Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Skin Disease Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Skin Disease Treatment Revenue Market Share, 2017-2028
Figure 12. US Skin Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Skin Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Skin Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Skin Disease Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Skin Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Skin Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Skin Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Skin Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Skin Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Skin Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Skin Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Skin Disease Treatment Revenue Market Share, 2017-2028
Figure 24. China Skin Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Skin Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Skin Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Skin Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Skin Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Skin Disease Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Skin Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Skin Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Skin Disease Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Skin Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Skin Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Skin Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Skin Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. APEIRON Biologics AG Skin Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. HanAll BioPharma Skin Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GlaxoSmithKline plc. Skin Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Allergen, Plc. Skin Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Anacor Pharmaceuticals Skin Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Celgene Skin Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Basilea Pharmaceutica Skin Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Cipher Pharmaceuticals Skin Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Agenus Skin Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Astion Pharma A/S Skin Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Bristol-Myers Squibb Skin Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Almirall S.A. Skin Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Galderma Skin Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)